Treatment of small cell lung cancer patients

This publication has 56 references indexed in Scilit:

• Carboplatin, etoposide, and accelerated hyperfractionated radiotherapy for elderly patients with limited small cell lung carcinoma
  Cancer, 1998
• Five-Day Oral Etoposide2 Treatment for Advanced Small-Cell Lung Cancer: Randomized Comparison With Intravenous Chemotherapy
  JNCI Journal of the National Cancer Institute, 1997
• Comparison of oral etoposide and standard intravenous multidrug chemotherapy for small-cell lung cancer: a stopped multicentre randomised trial
  The Lancet, 1996
• Maintenance chemotherapy in small-cell lung cancer: long-term results of a randomized trial. European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group.
  Journal of Clinical Oncology, 1993
• Chemotherapy of Lung Cancer
  New England Journal of Medicine, 1992
• Randomized study of cyclophosphamide, doxorubicin, and vincristine versus etoposide and cisplatin versus alternation of these two regimens in extensive small-cell lung cancer: a phase III trial of the Southeastern Cancer Study Group.
  Journal of Clinical Oncology, 1992
• Randomized Trial of Cyclophosphamide, Doxorubicin, and Vincristine Versus Cisplatin and Etoposide Versus Alternation of These Regimens in Small-Cell Lung Cancer
  JNCI Journal of the National Cancer Institute, 1991
• Carboplatin dosage: prospective evaluation of a simple formula based on renal function.
  Journal of Clinical Oncology, 1989
• Controlled trial of twelve versus six courses of chemotherapy in the treatment of small-cell lung cancer
  British Journal of Cancer, 1989
• Superiority of Alternating Non-Cross-Resistant Chemotherapy in Extensive Small Cell Lung Cancer
  Annals of Internal Medicine, 1987